FDA Drug Recalls

Recalls / Class II

Class IID-0627-2018

Product

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches Rx Only NDC 68968-5552-3 Manufactured for Noven Therapeutics, LLC., Miami, FL 33186 by Noven Pharmaceuticals, Inc. Miami, FL 33186 1-877-567-7857

Brand name
Daytrana
Generic name
Methylphenidate
Active ingredient
Methylphenidate
Route
Transdermal
NDCs
68968-5552, 68968-5553, 68968-5554, 68968-5555
FDA application
NDA021514
Affected lot / code info
Lot #: 82237 Exp. May 31, 2018

Why it was recalled

Defective Delivery System: Out of specification for adhesive transfer.

Recalling firm

Firm
Noven Pharmaceuticals, Inc.
Manufacturer
Noven Therapeutics, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
11960 SW 144th St, Miami, Florida 33186-6109

Distribution

Quantity
9016 boxes of 30 patch each
Distribution pattern
Nationwide.

Timeline

Recall initiated
2018-04-09
FDA classified
2018-04-13
Posted by FDA
2018-04-25
Terminated
2020-01-24
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0627-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Daytrana · FDA Drug Recalls